Premium
Patient and caregiver reactions to clinical amyloid imaging
Author(s) -
Grill Joshua D.,
Cox Chelsea G.,
Kremen Sarah,
Mendez Mario F.,
Teng Edmond,
Shapira Jill,
Ringman John M.,
Apostolova Liana G.
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.01.001
Subject(s) - dementia , amyloid (mycology) , neuroimaging , positron emission tomography , medicine , pet imaging , set (abstract data type) , psychology , disease , medical physics , radiology , psychiatry , pathology , computer science , programming language
Amyloid imaging is a tool that has recently become available to dementia specialists evaluating patients with possible Alzheimer's disease. Studies have assessed the impact of amyloid imaging on diagnostic and treatment decisions, but patient and family perspectives have received less attention. Methods To examine how amyloid imaging affects the diagnostic experience of patients and families, we interviewed members of 26 patient‐caregiver dyads with whom a neurologist discussed the option of amyloid positron emission tomography. Results Most participants who chose to undergo amyloid imaging would choose to do so again. Regardless of the scan outcome, patients and caregivers commonly expressed relief on learning the scan results. Some participants expressed expectations that were beyond scan capabilities. Discussion Amyloid imaging may provide information that patients and their families find useful. Clinicians must set correct expectations and ensure that families understand the limitations of amyloid imaging.